BASF (BAS) CMD 2025 summary

Strategic progress, transformation, and portfolio updates

• One year into the new strategy, focus remains on portfolio steering, capital allocation, and performance culture, with significant progress despite macroeconomic headwinds.

• Portfolio is split into core and standalone businesses; core targets €7–9B EBITDA by 2028 (from €5.4B), while standalone businesses are being optimized for value extraction, including carve-outs, divestitures, and IPO preparations.

• Automotive catalysts (ECMS) is expected to contribute €4B cumulative cash flow by 2030 and will remain part of the group due to strong cash generation.

• Decorative paints business in Brazil was divested for $1.15B; further value unlocking in coatings is underway, with a decision expected in Q4 2025.

• Agricultural Solutions is being carved out for a partial IPO by 2027, with internal preparations progressing on schedule.

Financial guidance, targets, and shareholder returns

• 2028 targets reconfirmed: €10–12B EBITDA before special items, €12B+ cumulative free cash flow (2025–2028), and ROCI/ROCE around 10%.

• Annual dividend policy of at least €2.25/share (2025–2028), totaling about €8B; share buybacks of at least €4B planned for 2027–2028, with potential for earlier start.

• Proceeds from divestments and ongoing portfolio measures to strengthen balance sheet and support accelerated buybacks.

• CapEx reduced from €17B to €16B through disciplined project management and savings, with major projects like Zhanjiang and the U.S. MDI plant nearing completion.

• Capex to be reduced below depreciation from 2026, with over 50% allocated to growth regions and green transformation.

Core business, value chain strategy, and operational excellence

• Core businesses have strong market positions (75% top three), robust innovation (15% of sales from products launched in last five years), and are the main engine for profitable growth.

• Integrated value chains (e.g., ethylene oxide, polyurethanes) are central, representing 50% of core business and providing resilience and value-add through the Verbund model.

• Zhanjiang Verbund site to start up in late 2025, with €8.7B CapEx (below budget); ramp-up will be slower due to market conditions, but long-term EBITDA target of €1–1.2B is maintained.

• Four underperforming areas in the core (e.g., butane diol, polyamides, plastic additives, vitamins) are targeted for €400M earnings lift by 2028 through restructuring and asset optimization.

• Workforce reduced by 3,000 (excluding Zhanjiang), and 10% of senior executive positions cut, reflecting accelerated organizational streamlining.